ADAR1 has also been shown to modify 3ʹ-UTR region of methyltransferase-like 3 (METTL3), an N6-methyladenosine (m6A) writer, and abrogates its interaction with miR-532-5p, resulting in increased METTL3 protein expression in BC cells (Li et al., 2022c). Here, ADAR is linked to breast cancer.